EPO case law update – T 1491/14 The EPO’s Technical Board of Appeal 3301 in recent decision T 1491/14 has provided further insight into the criteria suitable for establishing novelty of… read more…
In this article for eeNews Europe, we consider the intellectual property (IP) issues in relation to likely developments in AI hardware In recent years, we have seen the use of artificial… read more…
In this article written by Managing IP, Mathys & Squire partner Martin MacLean provides his expert opinion on vaccine development during the midst of the COVID-19 global pandemic Martin… read more…
In this article for Managing IP, Mathys & Squire partner Anna Gregson explains why early adoption of a robust patent strategy in the search for a COVID-19 vaccine is crucial, particularly as the… read more…
Chancellor Rishi Sunak delivered his first Budget in the House of Commons yesterday (11 March) One of the key focus areas for the 2020 Budget, in line with consumer concerns relating to… read more…
In this article for Business & Innovation Magazine, we summarise Mathys & Squire’s recent seminar entitled ‘Developing & implementing a commercially robust IP strategy’ IP… read more…
The British Government has announced that the UK will not be participating in the proposed Unitary Patent and Unified Patent Court (UPC) This puts an end to several years of speculation following… read more…
As competition drives innovation and awakens the creative spirit, we discover that brand identity is, now more than ever, paramount to staying memorable It is therefore not surprising that… read more…
In this article for Open Access Government, Mathys & Squire managing associate Charlie Dempster provides a focus on chemistry, specifically detailing nanocellulose in water… read more…